Jan Lehmann

Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group

Peter Albers, Roswitha Siener, S. Krege et al. · Journal of Clinical Oncology · 2008 · 337 citations

Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial

Jürgen E. Gschwend, Matthias Heck, Jan Lehmann et al. · European Urology · 2018 · 331 citations

Urology, Surgical Oncology, Genitourinary Cancer +6

Antitumor Activity of the Antimicrobial Peptide Magainin II against Bladder Cancer Cell Lines

Jan Lehmann, Margitta Retz, Sukhvinder Sidhu et al. · European Urology · 2006 · 221 citations

Urology, Antitumor Activity, Medicine +7

Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells

H. Suttmann, Margitta Retz, Friedrich Paulsen et al. · BMC Urology · 2008 · 169 citations · Full text

A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment

Steven C. Smith, Alexander S. Baras, Garrett M. Dancik et al. · The Lancet Oncology · 2011 · 148 citations · Full text

Tumor Biology, Urological Research, Urology +12